---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-314430"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:40:05.924373+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics prices public offering of 6.14M shares at $42.50, raising ~$260.9M

## Summary
- Entered underwriting agreement Dec 9 to sell 6,138,108 shares of common stock at $42.50/share.
- Gross proceeds to company approximately $260.9 million before underwriting discounts and expenses.
- Underwriters fully exercised 30-day over-allotment option for 920,716 additional shares on Dec 10.
- Offering expected to close Dec 11, 2025, subject to customary conditions.
- Shares offered under existing automatic shelf registration statement (File No. 333-282861).

## SEC filing metadata
- accession: 0001193125-25-314430
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312525314430/0001193125-25-314430-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312525314430/d870139d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-314430
- JSON: https://secwatch.observer/filing/0001193125-25-314430.json
- Plain text: https://secwatch.observer/filing/0001193125-25-314430.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.